8 of 11

Setting the Agenda

Vertex CEO and BIO chairman Joshua Boger (left) with BIO CEO Jim Greenwood lay out the industry's legislative agenda at a press conference during the JPMorgan Healthcare Conference. Among the group's top concerns are patent reform and the development of a pathway for follow-on or generic biologics.